×

img Accessibility Controls

Technologies Banner

All Technologies

Dry Powder Inhalation of Particles Containing Anti-tuberculosis Drugs

Implementing Organization

Project Overview

Treatment of pulmonary TB with orally-administered drugs is sub-optimal-exposing non-target tissues to toxic drugs and requiring large doses to build up effective concentrations in lungs . Prolonged dosing is required to build up and maintain effective concentrations in lungs . Patients remain infectious for considerable periods after initiating drug treatment.

Benefits

It is safe and helps is reducing drug intake over time thereby reducing duration of treatment.

Source

Quick Information
Thrust Areas
Medical Sciences
Focus Area
Treatment of Pulmonary TB
Output
TRL: Technology Readiness Level
Technology Demonstration
Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
arrowtop
Latest Updates
Loading…